⌘K

Home/Filings/4/0000899243-22-030439

4//SEC Filing

Dion Gisele 4

Accession 0000899243-22-030439

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Sep 5, 8:00 PM ET

Accepted

Sep 6, 5:08 PM ET

Size

5.3 KB

Accession

0000899243-22-030439

Insider Transaction Report

Form 4

Period: 2022-09-01

Inhibikase Therapeutics, Inc.IKT

Director

Transactions

Award
Stock Option (right to buy)
2022-09-01+60,000→ 60,000 total
Exercise: $0.95Exp: 2032-09-01→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]The option shares vest 50% on each of the first two anniversaries of September 1, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0001873088

Filing Metadata

Form type: 4
Filed: Sep 5, 8:00 PM ET
Accepted: Sep 6, 5:08 PM ET
Size: 5.3 KB

View on SEC.gov